Clinical and Translational Science Award

Last updated

Clinical and Translational Science Award (CTSA) is a type of U.S. federal grant administered by the National Center for Advancing Translational Sciences, part of the National Institutes of Health. The CTSA program began in October 2006 under the auspices of the National Center for Research Resources with a consortium of 12 academic health centers. The program was fully implemented in 2012, comprising 60 grantee institutions and their partners. [1]

Contents

Program overview

The CTSA program helps institutions create an integrated academic home for clinical and translational science with the resources to support researchers and research teams working to apply new knowledge and techniques to patient care. The program is structured to encourage collaborations among researchers from different scientific fields. [2]

The CTSA program has raised awareness of clinical and translational science as a discipline among academic and industry researchers, philanthropists, government officials and the broader public. [3]

Strategic goals

CTSA consortium leaders have set five broad goals to guide their activities. These include building national clinical and translational research capability, providing training and improving career development of clinical and translational scientists, enhancing consortium-wide collaborations, improving the health of U.S. communities and the nation, and advancing T1 translational research to move basic laboratory discoveries and knowledge into clinical testing. [4]

Selected research areas

Institutions funded by the CTSA program are working with other research facilities to improve drug discovery and development. For example, several consortium institutions are collaborating with the Rat Resource and Research Center at the University of Missouri to increase the speed of drug screening so that drug research is translated into clinical uses more quickly. [5] Consortium institutions also are creating new fields of study or new uses for technologies. For example, researchers at the University of Rochester are pioneering the field of lipidomics, exploring how lipids affect human disease. Their work has led to lipid research collaborations among experts in community and preventive medicine, proteomics, nutrition, and pharmaceutical research. [6]

Some CTSA institutions are collaborating with community-based organizations to ensure research is translated successfully into clinical practice. Researchers at Duke University are working to prevent strokes by partnering with a local health care program to build stroke awareness among Latino immigrants. [7]

Others are pursuing public and private partnerships to speed innovation. For example, the Oregon Health and Science University and Intel are developing new wireless devices with sensors to detect symptoms in patients who have diabetes or those at high risk of stroke so they can be treated earlier. [8]

Participating institutions

With the most recent awards, announced in July 2011, the consortium comprises 60 institutions in 30 states and the District of Columbia. [9] These include: [10]

Investigations by the Department of Health and Human Services Office of Inspector General (OIG)

On the 20 December 2011, the OIG published a report critical of the NIH's administration of the Clinical and Translational Science Awards (CTSA) program. [11] The report read in part:

For all 38 Clinical and Translational Science Awards (CTSA) cooperative agreements awarded from 2006 through 2008, CTSA program staff did not document awardees' progress in compliance with NIH policy.

CTSA program staff must ensure that awardees submit annual progress reports and financial status reports, determine whether awardee progress remains satisfactory before awardees receive continued funding, and maintain official files in accordance with Department of Health and Human Services (HHS) policy. Additionally, under cooperative agreements, CTSA program staff provide assistance to awardees above and beyond the levels usually required for program stewardship of grants. This level of stewardship is known as substantial involvement. CTSA program staff assign NIH Project Scientists to awardees to provide this substantial involvement through technical assistance, advice, and coordination. Names of substantially involved staff and an annual summary of staff involvement should be documented in the official files.

CTSA program staff documented a comparison of accomplishments to research objectives for only 1 of 38 awardees throughout our review period. Although reviews for six awardees' files mentioned an inability to fulfill goals, only one file included a note from CTSA program staff regarding resolution. Also, most progress reports and half of financial status reports were late, yet the files contained no evidence that CTSA program staff took action to address timeliness of reports. CTSA program staff did not maintain files in accordance with HHS policy. Finally, no files contained evidence that CTSA program staff provided substantial involvement to awardees in accordance with Federal requirements and NIH policy.

We recommend that NIH ensure that CTSA program staff (1) document their monitoring of awardee progress; (2) ensure timely submission of required reports; (3) maintain official files in accordance with Federal policy; and (4) as required for cooperative agreements, provide substantial involvement to CTSA awardees. NIH concurred with our recommendations.

See also

Related Research Articles

<span class="mw-page-title-main">National Institutes of Health</span> US government medical research agency

The National Institutes of Health, commonly referred to as NIH, is the primary agency of the United States government responsible for biomedical and public health research. It was founded in the late 1880s and is now part of the United States Department of Health and Human Services. Many NIH facilities are located in Bethesda, Maryland, and other nearby suburbs of the Washington metropolitan area, with other primary facilities in the Research Triangle Park in North Carolina and smaller satellite facilities located around the United States. The NIH conducts its own scientific research through the NIH Intramural Research Program (IRP) and provides major biomedical research funding to non-NIH research facilities through its Extramural Research Program.

The University of North Texas Health Science Center is a public academic health science center in Fort Worth, Texas. It is part of the University of North Texas System and was founded in 1966 as the Texas College of Osteopathic Medicine, with its first cohort admitted in 1970. UNT Health Science Center consists of six schools with a total enrollment of 2,329 students (2020–21).

Translational medicine develops the clinical practice applications of the basic science aspects of the biomedical sciences; that is, it translates basic science to applied science in medical practice. It is defined by the European Society for Translational Medicine as "an interdisciplinary branch of the biomedical field supported by three main pillars: benchside, bedside, and community". The goal of translational medicine is to combine disciplines, resources, expertise, and techniques within these pillars to promote enhancements in prevention, diagnosis, and therapies. Accordingly, translational medicine is a highly interdisciplinary field, the primary goal of which is to coalesce assets of various natures within the individual pillars in order to improve the global healthcare system significantly.

<span class="mw-page-title-main">University of Nebraska Medical Center</span> Medical center in Omaha, Nebraska, United States

The University of Nebraska Medical Center (UNMC) is a public academic health science center in Omaha, Nebraska. Founded in 1869 and chartered as a private medical college in 1881, UNMC became part of the University of Nebraska System in 1902. Rapidly expanding in the early 20th century, the university founded a hospital, dental college, pharmacy college, college of nursing, and college of medicine. It later added colleges of public health and allied health professions. One of Omaha's top employers, UNMC has an annual budget of $841.6 million for 2020 to 2021, and an economic impact of $4.8 billion.

The National Center for Research Resources (NCRR) was a center within the National Institutes of Health, a United States government agency. NCRR provided funding to laboratory scientists and researchers for facilities and tools in the goal of curing and treating diseases.

<span class="mw-page-title-main">Eric Topol</span> American cardiologist, scientist, and author

Eric Jeffrey Topol is an American cardiologist, scientist, and author. He is the founder and director of the Scripps Research Translational Institute, a professor of Molecular Medicine and Executive Vice-President at Scripps Research Institute, and a senior consultant at the Division of Cardiovascular Diseases at Scripps Clinic in La Jolla, California. He is editor-in-chief of Medscape and theheart.org. He has published three bestseller books on the future of medicine: The Creative Destruction of Medicine (2010), The Patient Will See You Now (2015), and Deep Medicine: How Artificial Intelligence Can Make Healthcare Human Again (2019). He was commissioned by the UK from 2018–2019 to lead planning for the National Health Service's future workforce, integrating genomics, digital medicine, and artificial intelligence.

Translational research is research aimed at translating (converting) results in basic research into results that directly benefit humans. The term is used in science and technology, especially in biology and medical science. As such, translational research forms a subset of applied research.

NCRR's IDeA Networks of Biomedical Research Excellence (INBRE) promote the development, coordination, and sharing of research resources and expertise that will expand the research opportunities and increase the number of competitive investigators in the IDeA-eligible states.

<span class="mw-page-title-main">University of Florida College of Medicine-Jacksonville</span> Medical school of the University of Florida in Jacksonville

The University of Florida College of Medicine – Jacksonville is the largest of the three University of Florida Health Science Center Jacksonville colleges — medicine, nursing and pharmacy. The college's 16 clinical science departments house more than 440 faculty members and 380 residents and fellows. The college offers 34 accredited graduate medical education programs and 10 non-standard programs.

REDCap is a browser-based, metadata-driven EDC software and workflow methodology for designing clinical and translational research databases. It is widely used in the academic research community: the REDCap Consortium is a collaborative, international network of more than 5900 institutional partners in 145 countries, with more than 2.1 million total end-users employing the software. Over 19,000 journal articles cite REDCap.

The Center for Study of Gene Structure and Function is a consortium of fifty-three researchers. It is based at Hunter College in Manhattan. It focuses on cross-disciplinary and translational research by promoting dialogue and cooperation among scientists working in diverse biomedical research fields. It is funded by the Research Centers in Minority Institutions (RCMI) program of the National Center for Research Resources(NCRR) of the National Institute of Health (NIH) Since its establishment in 1985, the NIH has awarded the Gene Center over $38 million in federal grants.

<span class="mw-page-title-main">Renaissance School of Medicine at Stony Brook University</span> Medical school of Stony Brook University

The Renaissance School of Medicine (RSOM) is the graduate medical school of Stony Brook University located in the hamlet of Stony Brook, New York on Long Island. Founded in 1971, RSOM is consistently ranked the top public medical school in New York according to U.S. News & World Report. RSOM is one of the five Health Sciences schools under the Stony Brook Medicine healthcare system.

<span class="mw-page-title-main">NIH Intramural Research Program</span> Internal research program of the National Institutes of Health

The NIH Intramural Research Program (IRP) is the internal research program of the National Institutes of Health (NIH), known for its synergistic approach to biomedical science. With 1,200 Principal Investigators and over 4,000 Postdoctoral Fellows conducting basic, translational, and clinical research, the NIH Intramural Research Program is the largest biomedical research institution on earth. The unique funding environment of the IRP facilitates opportunities to conduct both long-term and high-impact science that would otherwise be difficult to undertake. With rigorous external reviews ensuring that only the most outstanding research secures funding, the IRP is responsible for many scientific accomplishments, including the discovery of fluoride to prevent tooth decay, the use of lithium to manage bipolar disorder, and the creation of vaccines against hepatitis, Hemophilus influenzae (Hib), and human papillomavirus (HPV). In addition, the IRP has also produced or trained 21 Nobel Prize-winning scientists.

The Rare Diseases Clinical Research Network (RDCRN) is an initiative of the US Office of Rare Diseases Research (ORDR). RDCRN is funded by the ORDR, the National Center for Advancing Translational Sciences and collaborating institute centers. The RDCRN is designed to advance medical research on rare diseases by providing support for clinical studies and facilitating collaboration, study enrollment and data sharing. Through the RDCRN consortia, physician scientists and their multidisciplinary teams work together with patient advocacy groups to study more than 200 rare diseases at sites across the nation.

<span class="mw-page-title-main">Foundation for the National Institutes of Health</span>

The Foundation for the National Institutes of Health (FNIH) is a not-for-profit, 501(c)(3) charitable organization established by the US Congress in 1990. Located in North Bethesda, MD, the FNIH raises private-sector funds, and creates and manages alliances with public and private institutions in support of the mission of the National Institutes of Health (NIH).

<span class="mw-page-title-main">Consuelo H. Wilkins</span>

Consuelo H. Wilkins is an American physician, biomedical researcher, and health equity expert. She is Senior Vice President and Senior Associate Dean for Health Equity and Inclusive Excellence at Vanderbilt University Medical Center. She is a professor of medicine in the Department of Medicine, Division of Geriatrics at Vanderbilt University School of Medicine and has a joint appointment at Meharry Medical College. She additionally serves as one of the principal investigators of the Vanderbilt Clinical and Translational Science Award, Director of the Meharry-Vanderbilt Community Engaged Research Core (CTSA) and as vice president for Health Equity at Vanderbilt University Medical Center.

<span class="mw-page-title-main">Judith Vaitukaitis</span> Reproductive neuroendocrinologist

Judith L. Vaitukaitis was a reproductive neuroendocrinologist and clinical researcher who played a key role in developing a biochemical assay in the early 1970s that ultimately led to the creation of the home pregnancy test. She served for 12 years as director of the US National Center for Research Resources (NCRR) at the US National Institutes of Health (NIH).

A physician-scientist is traditionally a holder of a medical degree and a doctor of philosophy also known as an MD-PhD. Compared to other clinicians, physician-scientists invest significant time and professional effort in scientific research and spend correspondingly less time in direct clinical practice with ratios of research to clinical time ranging from 50/50 to 80/20. Physician-scientists are often employed by academic or research institutions where they drive innovation across a wide range of medical specialties and may also use their extensive training to focus their clinical practices on specialized patient populations, such as those with rare genetic diseases or cancers. Although they are a minority of both practicing physicians and active research scientists, physician-scientists are often cited as playing a critical role in translational medicine and clinical research by adapting biomedical research findings to health care applications. Over time, the term physician scientist has expanded to holders of other clinical degrees—such as nurses, dentists, and veterinarians— who are also included by the United States National Institutes of Health in its studies of the physician-scientist workforce (PSW).

<span class="mw-page-title-main">Gary Firestein</span> American rheumatologist

Gary S. Firestein is an American rheumatologist, professor, and founding director of the Altman Clinical and Translational Research Institute (ACTRI) at the University of California San Diego and Senior Associate Vice Chancellor for Health Sciences at University of California, San Diego.

Leigh Ebony Boulware is an American general internist, physician-scientist, and clinical epidemiologist. She is the Dean of Wake Forest School of Medicine and chief science officer and vice chief academic officer of Advocate Health. Boulware formerly served as the Nanaline Duke Distinguished Professor of Medicine and director of the Clinical and Translational Science Institute at the Duke University School of Medicine.

References

  1. ↑ National Institutes of Health (Sep 17, 2009). "Re-engineering the Clinical Research Enterprise: Translational Research". Archived from the original on May 29, 2010. Retrieved June 18, 2010.
  2. ↑ National Institutes of Health (Jan 26, 2010). "Institutional Clinical and Translational Science Award (U54)" . Retrieved June 18, 2010.
  3. ↑ Society for Clinical; Translational Science (May 22, 2009). "Presidents Letter" . Retrieved June 29, 2010.
  4. ↑ National Center for Research Resources (Fall 2009). "NCRR Fact Sheet: Clinical and Translational Science Awards" (PDF). Archived from the original (PDF) on May 27, 2010. Retrieved June 18, 2010.
  5. ↑ National Center for Research Resources (Fall 2009). "NCRR Fact Sheet: Clinical and Translational Science Awards" (PDF). Archived from the original (PDF) on May 27, 2010. Retrieved June 18, 2010.
  6. ↑ National Center for Research Resources (Fall 2009). "NCRR Fact Sheet: Clinical and Translational Science Awards" (PDF). Archived from the original (PDF) on May 27, 2010. Retrieved June 18, 2010.
  7. ↑ National Center for Research Resources (Fall 2009). "NCRR Fact Sheet: Clinical and Translational Science Awards" (PDF). Archived from the original (PDF) on May 27, 2010. Retrieved June 18, 2010.
  8. ↑ National Center for Research Resources (Fall 2009). "NCRR Fact Sheet: Clinical and Translational Science Awards" (PDF). Archived from the original (PDF) on May 27, 2010. Retrieved June 18, 2010.
  9. ↑ National Institutes of Health (July 22, 2011). "NIH Announces Five New Clinical and Translational Science Awards". Archived from the original on September 16, 2011. Retrieved July 22, 2011.
  10. ↑ Clinical and Translational Science Awards Consortium (September 7, 2011). "CTSA Institutions". Archived from the original on September 8, 2011. Retrieved September 7, 2011.
  11. ↑ "NIH Administration of the Clinical and Translational Science Awards Program (Report OEI-07-09-00300)" (PDF). December 2011. Retrieved 2011-12-22.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.